Lars Rebien Sørensen became the CEO and President of Novo Nordisk’s Enzymes Marketing in 2000. He joined the company in 1982 and held a variety of positions within it around the world, including the Middle East. Twelve years after coming on board, Sørensen became a member of Corporate Management and shortly thereafter, he took on additional responsibility within Corporate Management for Health Care.